Theravance, Inc.
387Patents
272Active
387Granted
53Portfolio score
Filing activity: Feb 19, 1999 → Jul 8, 2013 · 197 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6693202B1 | Muscarinic receptor antagonists | Chemistry; Metallurgy | 138 | Expired |
| US7858583B2 | Process for purifying glycopeptide phosphonate derivatives | Chemistry; Metallurgy | 90 | Active |
| US7141671B2 | Biphenyl derivatives | Physics | 85 | Expired |
| US6635764B2 | Therapeutic ureas | Chemistry; Metallurgy | 81 | Expired |
| US8513244B2 | Neprilysin inhibitors | Chemistry; Metallurgy | 76 | Active |
| US8449890B2 | Neprilysin inhibitors | Chemistry; Metallurgy | 68 | Active |
| US8586536B2 | Neprilysin inhibitors | Chemistry; Metallurgy | 68 | Active |
| US8481044B2 | Neprilysin inhibitors | Chemistry; Metallurgy | 66 | Active |
| US8563512B2 | Neprilysin inhibitors | Emerging Cross-Sectional Technologies | 63 | Active |
| US8686184B2 | Neprilysin inhibitors | Chemistry; Metallurgy | 62 | Active |
| US6670376B1 | Aryl aniline &bgr;2 adrenergic receptor agonists | Chemistry; Metallurgy | 62 | Expired |
| US6541669B1 | &bgr;2-adrenergic receptor agonists | Physics | 59 | Expired |
| US8691868B2 | Neprilysin inhibitors | Human Necessities | 57 | Active |
| US6656694B2 | Method for identifying a ligand for a biological substrate | Emerging Cross-Sectional Technologies | 51 | Expired |
| US6576793B1 | &bgr;2-adrenergic receptor agonists | Chemistry; Metallurgy | 49 | Expired |
| US7288657B2 | Biphenyl compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 49 | Expired |
| US7265133B2 | Biphenyl compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 45 | Expired |
| US6653323B2 | Aryl aniline &bgr;2 adrenergic receptor agonists | Chemistry; Metallurgy | 44 | Expired |
| US6747043B2 | Alkoxy aryl &bgr;2 adrenergic receptor agonists | Chemistry; Metallurgy | 41 | Expired |
| US7345060B2 | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity | Chemistry; Metallurgy | 40 | Expired |
| US7879896B2 | Dual-acting imidazole antihypertensive agents | Chemistry; Metallurgy | 40 | Active |
| US7456199B2 | Biphenyl compounds useful as muscarinic receptor antagonists | Human Necessities | 37 | Expired |
| US7279458B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Chemistry; Metallurgy | 36 | Expired |
| US8013005B2 | Dual-acting antihypertensive agents | Chemistry; Metallurgy | 36 | Active |
| US7700777B2 | Crystalline forms of a biphenyl compound | Chemistry; Metallurgy | 36 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.